The Top Clinical News Stories This Month - January 2015

The clinical diagnostics industry is starting the year off with a bang. Here is a round-up just some of the most popular articles published this month.

Beckman Coulter Receives FDA Clearance on Vitamin D Total Assay for Use on Access 2 and UniCel DxI Immunoassay Systems
Beckman Coulter announces this important addition to the company’s bone metabolism assay menu. It is available for use on its Access 2 and UniCel DxI series of immunoassay systems.
Read full article

Abbott Acquires Exclusive License for Bladder Cancer Biomarker
Abbott Molecular announces that it has acquired exclusive rights for FGFR3 gene mutations for use in bladder cancer from Institut Curie. The FGFR3 biomarker can be used for early detection, disease monitoring and predicting patient outcomes, using both urine and tissue-based testing.
Read full article

Revolutionize Routine Medical Testing with Latest ‘Super-Control’ from Randox
The FDA has cleared Randox’s Acusera Liquid Assayed Chemistry Premium Plus control for use in US laboratories. A multi-analyte ‘super control’, it contains 100 of the most commonly used analytes in routine medical testing and Randox believes it will revolutionize QC testing in laboratories.
Read full article

Thermo Fisher Scientific Releases New CE-IVD Tumor Panel for Next Generation Sequencing
Thermo Fisher Scientific releases the new CE-IVD Oncomine Solid Tumor DNA kit, enabling highly accurate and reliable multiplexed sequencing of formalin-fixed, paraffin embedded (FFPE) tumor samples with the quality and performance needed for the clinical laboratory.
Read full article

New Whole Blood Assay May Help Overcome Roadblocks to TB Eradication
A new multiple-target, real-time reverse transcription-PCR (real-time RT-PCR) TaqMan assay targeting eight human immune markers can differentiate active pulmonary TB from LTBI, according to a study in The Journal of Molecular Diagnostics.
Read full article